Distinct endocannabinoid system functions in alcohol addiction and fetal alcohol effects

A review of preclinical evidence shows the endocannabinoid system plays distinct roles in alcohol addiction (through CB1 receptors in reward circuits) and fetal alcohol spectrum disorders (through developmental ECS disruption), suggesting different therapeutic targets for each.

Basavarajappa, Balapal S et al.·British journal of pharmacology·2019·Moderate EvidenceReview
RTHC-01935ReviewModerate Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

The ECS plays a major role in the motivation to abuse alcohol, with chronic alcohol consumption modulating endocannabinoids and CB1 receptor expression in brain addiction circuits. Separately, the ECS has a distinct function in the development of fetal alcohol spectrum disorders, suggesting these are mechanistically separable processes.

Key Numbers

CB1 receptors are present in inhibitory and excitatory presynaptic terminals. CB2 receptors found in neuronal subpopulations, microglia, and astrocytes at both pre- and postsynaptic terminals. Chronic alcohol modulates eCBs and CB1R expression in addiction circuits.

How They Did This

Comprehensive review assessing recent literature on the function of the endocannabinoid system in alcohol abuse disorders, covering both adult addiction pathways and developmental effects.

Why This Research Matters

By distinguishing the ECS roles in alcohol addiction versus fetal alcohol effects, this review clarifies that different therapeutic strategies may be needed for each condition rather than a one-size-fits-all approach to ECS manipulation.

The Bigger Picture

The distinction between ECS roles in adult addiction versus developmental disorders suggests the system is not monolithic. Different components of the ECS may need to be targeted differently depending on whether the goal is treating addiction or preventing developmental harm.

What This Study Doesn't Tell Us

Primarily based on preclinical data. The distinction between "distinct functions" may be more nuanced than presented. Clinical applications of ECS-targeted therapies for alcohol disorders remain theoretical.

Questions This Raises

  • ?Can ECS-targeted therapies be developed that address alcohol addiction without affecting developmental pathways?
  • ?Are the distinct ECS functions in addiction versus FASD mediated by different receptor subtypes or different brain regions?

Trust & Context

Key Stat:
Distinct ECS functions
Evidence Grade:
Rated moderate because the review synthesizes substantial preclinical evidence with a clear mechanistic framework.
Study Age:
Published in 2019 in the British Journal of Pharmacology.
Original Title:
Distinct functions of endogenous cannabinoid system in alcohol abuse disorders.
Published In:
British journal of pharmacology, 176(17), 3085-3109 (2019)
Database ID:
RTHC-01935

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research on a topic.

What do these levels mean? →

Frequently Asked Questions

How does the endocannabinoid system relate to alcohol addiction?

Chronic alcohol changes endocannabinoid levels and CB1 receptor expression in brain reward and addiction circuits, contributing to the drive to continue drinking.

Is the ECS involvement the same in fetal alcohol effects?

No. This review argues the ECS plays a distinct role in fetal alcohol spectrum disorders through developmental disruption, which is mechanistically different from its role in adult addiction.

Read More on RethinkTHC

Cite This Study

RTHC-01935·https://rethinkthc.com/research/RTHC-01935

APA

Basavarajappa, Balapal S; Joshi, Vikram; Shivakumar, Madhu; Subbanna, Shivakumar. (2019). Distinct functions of endogenous cannabinoid system in alcohol abuse disorders.. British journal of pharmacology, 176(17), 3085-3109. https://doi.org/10.1111/bph.14780

MLA

Basavarajappa, Balapal S, et al. "Distinct functions of endogenous cannabinoid system in alcohol abuse disorders.." British journal of pharmacology, 2019. https://doi.org/10.1111/bph.14780

RethinkTHC

RethinkTHC Research Database. "Distinct functions of endogenous cannabinoid system in alcoh..." RTHC-01935. Retrieved from https://rethinkthc.com/research/basavarajappa-2019-distinct-functions-of-endogenous

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.